GSFQ) is a specific Quality of Life (QoL) instrument which measures the impact of GERD symptoms on QoL. This study aims to adapt the GSFQ into Spanish (for Spain) culture and check the questionnaire psychometric properties. METHODS: An expert panel composed by a gastroenterologist, two methodologists, one expert in clinical research and one pharmacoeconomist supervised the adaptation process. The original instrument was translated and back-translated by two independent translators. For psychometric measures, a small sample was used to check the initial comprehension and factibility. A national representative sample was selected, stratified by gender, age (<45, Ն45 years) and GERD severity (0-I, ՆII, Savary-Miller score). Content validity was ensured by the original instrument. Cronbach's Alfa was used to assess reliability, and exploratory factor analysis to assess dimensionality. The EuroQol questionnaire and corresponding Visual analogue scales (VAS) were used for concurrent validity. RESULTS: A total of 3997 patients with pyrosis symptoms were recruited by 490 clinicians. Mean age was 49.35 (14.35) years and 48.4% were women. No ceiling or floor effects were detected in item responses. The reliability was good (0.864) and only 1 dimension exhibited an eigenvalue (3.45) above 1, explaining 58% of available variability. All items loaded on this dimension. Correlation were moderate but significant (p < 0.001) with EuroQol (0.499) and VAS (-0.481). The average score was 34.17 (19.685), in the 0-100 scale. Mean scores were significantly different between GERD diagnosed severity levels (F4,33035 = 84.9, p < 0.005), but no differences were found between Savary-Miller level IV and levels II-III. CON-CLUSION: The Spanish version of the GSFQ has good psychometric properties, behaves as a unidimensional scale, and is capable to discriminate between patients with varying degrees of GERD severity.
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PGI25 DEVELOPMENT AND VALIDATION OF PATIENT REPORTED OUTCOMES MEASUREMENT SCALES FOR CROHN'S DISEASE: THE INFLAMMATORY BOWEL DISEASE IMPACT AND SYMPTOM SCALES (IBDIMSYS)
Rauchensteiner S 1 , Miltenburger C 2 , Schaefer M 3 1 Charité Universitaetsmedizin Berlin, Berlin, Germany, 2 Bayer Schering Pharma AG, Berlin, Germany, 3 Institut für Klinische Pharmakologie, Berlin, Germany OBJECTIVES: According to recently published guidelines, treatments effects on patient's health status should be measured by validated disease-specific Patient Reported Outcomes concepts. The aim of this study is to develop and validate a PRO questionnaire based on a conceptual framework for Crohn's disease. METHODS: An item pool of 77 items was generated through in focus groups and validated in a German sample (n = 104). Other data included the SF-36 and IBDQ. RESULTS: A principal component analysis revealed 7 independent factors: impact, intimacy, abdominal pain, bowel movements, nausea, extraintestinal problems and night sweat. The impact factor was shown to comprise further three interpretable domains: emotional, social, and physical. CONCLUSION: Symptoms and consequences of Crohn's disease need to be measured separately, since their constituent items do not load on the same factors. Further investigation could reduce the amount of items of one concept or find further items for relevant aspects such as problems with intimacy.
PGI26 VALIDATED MEASURES OF HEALTH RELATED QUALITY OF LIFE AND PRODUCTIVITY IN A POPULATION OF PATIENTS REPORTING CHRONIC CONSTIPATION
Bolge SC 1 , Baran RW 2 1 Consumer Health Sciences, Princeton, NJ, USA, 2 Takeda Global Research and Development Center, Inc, Deerfield, IL, USA OBJECTIVES: To quantify the effects of chronic constipation on health-related quality of life, work productivity, and activity impairment. METHODS: Data are taken from the 2005 U.S. National Health and Wellness Survey, an annual cross-sectional study of the health care attitudes and behaviors of adults (age 18+). Chronic constipation sufferers are defined as experiencing chronic constipation in the past twelve months, and non-sufferers have not experienced chronic constipation. Respondents who experience inflammatory bowel disease or irritable bowel syndrome are excluded from the analysis. Quality of life is defined using the SF-8. The Work Productivity and Activity Impairment (WPAI) scale is used to quantify productivity loss. Linear regression models are used to control for potential confounders including demographics, number of physical comorbid conditions, and experiencing psychiatric comorbid conditions. RESULTS: The sample includes 1,288 (3%) chronic constipation sufferers and 35,676 (97%) non-sufferers. Chronic constipation sufferers have significantly worse mean physical (40.08 versus 48.79, p < 0.001) and mental (42.13 versus 49.75, p < 0.001) quality of life than non-sufferers. Controlling for potential confounders, constipation sufferers have SF-8 physical summary scores that are 3.550 (p < 0.001) points lower and SF-8 mental summary scores that are 2.891 (p < 0.001) points lower than non-sufferers. Among respondents employed full-time, chronic constipation sufferers have significantly greater productivity loss due to absenteeism (8.35 versus 3.10, p < 0.001), presenteeism (29.36 versus 13.36, p < 0.001), and overall (25.54 versus 12.18, p < 0.001). Controlling for potential confounders, constipation sufferers have greater absenteeism scores (3.102 points higher, p < 0.001), presenteeism scores (7.782 points higher, p < 0.001), and overall work productivity loss (6.017 points higher, p < 0.001) than non-sufferers. Chronic constipation sufferers also experience greater activity impairment (48.71 versus 21.75, p < 0.001) than non-sufferers, and have activity impairment scores 11.708 higher (p < 0.001) after controlling for potential confounders. CON-CLUSION: Chronic constipation has significant negative effects on physical and mental quality of life, work productivity, and activity impairment.
PGI27

ESTIMATION OF WEIGHTS FOR THE SPANISH VERSION OF SF-6D TO DERIVE SOCIETAL HEALTH STATE VALUES USING THE SPANISH VERSION OF SF-36V1
Ruiz MA 1 , Rejas J 2 , Pardo A 1 ,Valdés C 3 , Ortega T 3 , Soto J 2 1 Universidad Autónoma de Madrid, Madrid, Spain, 2 Pfizer Spain, Madrid, Spain, 3 Hospital Universitario Central de Asturias, Oviedo, Spain OBJECTIVES: To obtain the multi-attribute utility function (MAUF) for the Spanish version of the Short Form 6-D (SF-6D) and to compare utilities values with those determined by the British MAUF. To determine the weights of SF-36v1 items conforming the SF-6D instrument. METHODS: A whole-nation representative sample of 2,549 subjects [48.9% men, 48.5 (14.01) years] with mild to severe degree of Gastroesophageal Reflux Disease was recruited by 500 clinicians selected at random and used for this analysis. The Spanish versions of SF-6D and EQ-5D questionnaires plus the corresponding visual analogue scale were self-completed. Attribute weights were estimated using a cat-Abstracts A359
